Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2016 08:45 ET | Source: Endocyte, inc

Endocyte Appoints Mike Sherman as President and Chief Executive Officer

WEST LAFAYETTE, Ind., June 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
May 26, 2016 16:01 ET | Source: Endocyte, Inc.

Endocyte to Announce Updated Data on EC1456 and EC1169 at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

WEST LAFAYETTE, Ind., May 26, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
May 04, 2016 08:00 ET | Source: Endocyte, Inc.

Endocyte Reports First Quarter 2016 Financial Results

- Data from Phase 1 Dose Escalation Studies of EC1456 and EC1169 to be Presented at ASCO -- Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 --...
April 27, 2016 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces First Quarter 2016 Earnings Conference Call

WEST LAFAYETTE, Ind., April 27, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, May 4th, at 8:30 a.m. EDT to...
April 19, 2016 09:01 ET | Source: Endocyte, Inc.

Endocyte Announces Promising Preclinical Data for Application of SMDC Technology in CAR T Cell Therapy in Late-Breaking Abstract at American Association for Cancer Research (AACR) Annual Meeting 2016

Poster demonstrates novel approach to a universal T cell overcoming key challenges of current chimeric antigen receptor (CAR) technologies/therapies Potentially meaningful application of SMDC...
April 11, 2016 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2016

WEST LAFAYETTE, Ind., April 11, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
March 02, 2016 16:01 ET | Source: Endocyte, Inc.

Endocyte Reports Fourth Quarter and Year End 2015 Financial Results and Provides Clinical and Pipeline Update

- EC1456 and EC1169 Advance in Phase 1 Dose Escalation Studies -- Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 -- Two New Clinical Development...
February 24, 2016 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Fourth Quarter and Full Year 2015 Earnings Conference Call

WEST LAFAYETTE, Ind., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Mar. 2, at 4:30 p.m. EST to discuss...
February 16, 2016 16:00 ET | Source: Endocyte, Inc.

Endocyte to Present at Upcoming Conferences

WEST LAFAYETTE, Ind., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
November 03, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte Reports Third Quarter 2015 Financial Results and Provides Update on Clinical Progress

- Dose Escalation for EC1456 and EC1169 Advance in Phase 1 Studies - - Conference Call Today at 4:30 p.m. EST - WEST LAFAYETTE, Ind., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc....